Seizures in fragile X syndrome: Characteristics and comorbid diagnoses

American Journal on Intellectual and Developmental Disabilities

Volumn 115, Issue 6, 2010, Pages 461-472

  Berry Kravis, Elizabeth ^a   Raspa, Melissa ^b   Loggin Hester, Lisa ^a   Bishop, Ellen ^b   Holiday, David ^b   Bailey Jr , Donald B ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ARTICLE; CHILD; COMORBIDITY; EPILEPSY; FAMILY HEALTH; FEMALE; FRAGILE X SYNDROME; HEALTH SURVEY; HOSPITALIZATION; HUMAN; MALE; ONSET AGE; PARENT; PHYSICIAN; PRESCHOOL CHILD; PREVALENCE; STATISTICS;

ADULT; AGE OF ONSET; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; EPILEPSY; FAMILY HEALTH; FEMALE; FRAGILE X SYNDROME; HEALTH SURVEYS; HUMANS; MALE; PARENTS; PHYSICIANS; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 79952114434     PISSN: 19447558     EISSN: None     Source Type: Journal    
DOI: 10.1352/1944-7558-115.6.461     Document Type: Review

References (35)

1. Bagni, C., & Greenough, W. T. (2005). From mRNP trafficking to spine dysmorphogenesis: The roots of fragile X syndrome. Nature Reviews, Neuroscience, 6, 376-387. (Pubitemid 40593483)
2. Bailey, D. B., Raspa, M., & Olmsted, M. (2010). Using survey data to answer questions about the nature and consequences of fragile X syndrome: Lessons learned from the National Fragile X Survey. Manuscript submitted for publication.
3. Bailey, D. B., Raspa, M., Olmsted, M., & Holiday, D. B. (2008). Co-occurring conditions associated with FMR1 gene variations: Findings from a national parent survey. American Journal of Medical Genetics, 146A, 2060-2069.
4. Belsito,K. M., Law, P.A., Kirk, K. S., Landa, R. J., & Zimmermann, A. W. (2001). Lamotrigine therapy for autistic disorder: A randomized doubleblind placebo-controlled trial. Journal of Autism and Developmental Disorders, 31, 175-181. (Pubitemid 37490163)
5. Berry-Kravis, E. (2002). Epilepsy in fragile X syndrome. Developmental Medicine and Child Neurology, 44, 724-728. (Pubitemid 35230036)
6. Berry-Kravis, E., Grossman, A. W., Crnic, L. S., & Greenough, W. T. (2002). Fragile X syndrome. Current Pediatrics, 2, 316-324.
7. Berry-Kravis, E., Hessl, D., Coffey, S., Hervey, C., Schneider, A., Yuhas, J., et al. (2009). Ascending single dose trial of fenobam in subjects with fragile X syndrome. Journal of Medical Genetics, 46, 266-271.
8. Chuang, S. C., Zhao, W., Bauschwitz, R., Yan, Q., Bianchi, R., & Wong, R. K. S. (2005). Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor- mediated synaptic responses in hippocampal slices of a fragile X mouse model. Journal of Neuroscience, 25, 8048-8055. (Pubitemid 41254408)
9. Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., et al. (1997). Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits. Proceedings of the National Academy of Science USA, 94, 5401-5404. (Pubitemid 27214795)
10. Deonna, T. & Roulet, E. (2006). Autistic spectrum disorder: Evaluating possible contributing or causal role of epilepsy. Epilepsia, 47(Suppl. 2), 79-82. (Pubitemid 44684629)
11. Devys, D., Lutz, Y., Rouyer, N., Bellocq, J. P., & Mandel, J. L. (1993). The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nature Genetics, 4, 335-340. (Pubitemid 23231479)
12. Fisher, L. D., & van Belle, G. (1993). Biostatistics: A methodology for the health sciences. New York: Wiley.
13. Garcia-Nonell, C., Ratera, E. R., Harris, S. W., Hessl, D., Ono, M. Y., Tartaglia, N., et al. (2008). Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder. American Journal of Medical Genetics, 146A, 1911-1916.
14. Grossman, A. W., Aldridge, G. M., Weiler, I. J., & William, G. T. (2006). Local protein synthesis and spine morphogenesis: Fragile X syndrome and beyond. Journal of Neuroscience, 26, 7151-7155.
15. Hagerman, P. J. (2008). The fragile X prevalence paradox. American Journal of Medical Genetics, 45, 498-499.
16. Hagerman, P. J., & Stafstrom, C. E. (2009). Origins of epilepsy in fragile X syndrome. Epilepsy Currents, 9, 108-112.
17. Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A. et al. (2009). Advances in the treatment of fragile X syndrome. Journal of Pediatrics, 123, 378-390.
18. Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002). Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proceedings of the National Academy of Science USA, 99, 7746-7750. (Pubitemid 34568762)
19. Kleinbaum, D., & Klein, M. (2002). Logistic regression: A self learning text. New York: Springer-Verlag.
20. Klugger, G., Bohm, I., Laub, M. C., & Waldenmaier, C. (1996). Epilepsy and fragile X gene mutations. Pediatric Neurology, 15, 358-360. (Pubitemid 26418939)
21. Lauterborn, J. C., Rex, C. S., Kramar, E., Chen, L. Y. Pandyarajan, V., Lynch, G., & Gall, C. M. (2007). Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome. Journal of Neuroscience, 27, 10685-10694. (Pubitemid 47535868)
22. Levisohn, P. M. (2007). The autism-epilepsy connection. Epilepsia, 48(Suppl. 9), 33-35. (Pubitemid 350198226)
23. Li, J., Pelletier, M. R., Velazquez, J-L. P., & Carlen, P. L. (2002). Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Molecular and Cellular Neurosciences, 19, 138-151. (Pubitemid 34211895)
24. Malloy, C. A., Murray, D. S., Kinsman, A., Castillo, T., Mitchell, F. J., Hickey, et al. (2009). Differences in clinical presentation of Trisomy 21 with and without autism. Journal of Intellectual Disability Research, 53, 143-151.
25. Musumeci, S. A., Bosco, P., Calabrese, G., Bakker, C., Giovanni, B., De Sarro, G. B., et al. (2000). Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia, 41, 19-23. (Pubitemid 30036849)
26. Musumeci, S. A., Ferri, R., Elia, M., Colognola, R. M., Bergonzi, P., & Tassinari, C. A. (1991). Epilepsy and fragile X syndrome: A follow-up study. American Journal of Medical Genetics, 38, 511-513.
27. Musumeci, S. A, Hagerman, R. J., Ferri, R., Bosco, P., Dalla Bernardina, B K., Tassinari, C. A., et al. (1999). Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia, 40, 1092-1099. (Pubitemid 29372623)
28. Rees, M., Diebold, U., Parker, K., Doose, H., Gardiner, R. M., & Whitehouse, W. P. (1993). Benign childhood epilepsy with centrotemporal spikes and the focal sharp wave trait is not linked to the fragile X region. Neuropediatrics, 24, 211-213. (Pubitemid 23266189)
29. Ronen, G. M., Richards, J. E., Cunningham, C., Secord, M., & Rosenbloom, D. (2000). Can sodium valproate improve learning in children with epileptiform bursts but without clinical seizures? Developmental Medicine and Child Neurology, 42, 751-755.
30. Sabaratman, M., Vroegop, P. G., & Gangadharan, S. K. (2001). Epilepsy and EEG findings in 18 males with fragile X syndrome. Seizure, 10, 60-63. (Pubitemid 32220055)
31. Spence, S. J., & Schneider,M. T. (2009). The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatric Research, 65, 599-605.
32. Tharp, B. R. (2004). Epileptic encephalopathies and their relationship to developmental disorders: Do spikes cause autism. Mental Retardation and Developmental Disability Research Reviews, 10, 132-134. (Pubitemid 39329020)
33. Verkek, A. J., Pieretti, M., Sutcliffe, J. S., Fu, Y. H., Kuhl, D. P., Pizzuti, A., et al. (1991). Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65, 905-914. (Pubitemid 121001321)
34. Volk, L. J., Pfeiffer, B. E., Gibson, J. R., & Huber, K. M. (2007). Multiple Gq-coupled receptors converge on a common protein synthesisdependent long-term depression that is affected in fragile X syndrome mental retardation. Journal of Neuroscience, 27, 11624-11634. (Pubitemid 350006892)
35. Weiler, I. J., Spangler, C. C., Klintsova, A.Y., Grossman, A. W., Kim, S. H. Bertaina-Anglade, V., et al. (2004). Fragile X mental retardation protein is necessary for neurotransmitter- activated protein translation at synapses. Proceedings of the National Academy of Science USA, 101, 17329-17330.